Panagora Asset Management’s Fortress Biotech FBIO Stock Holding History

Panagora Asset Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$202K	Buy	66,025 +9,357	+17%	+$24.1K	﹤0.01%	1125
2026 Q1	$158K	Hold	56,668	–	–	﹤0.01%	1116
2025 Q4	$207K	Buy	56,668 +20,556	+57%	+$58.6K	﹤0.01%	1113
2025 Q3	$133K	Sell	36,112 -13,953	-28%	-$35.3K	﹤0.01%	1115
2025 Q2	$93.1K	Buy	+50,065	New	+$86.7K	﹤0.01%	1092
2021 Q3	–	Sell	-183	Closed	-$10K	–	1935
2021 Q2	$10K	Sell	183 -377	-67%	-$22.7K	﹤0.01%	2254
2021 Q1	$30K	Sell	560 -27	-5%	-$1.52K	﹤0.01%	2258
2020 Q4	$28K	Sell	587 -25,157	-98%	-$1.09M	﹤0.01%	2140
2020 Q3	$1.56M	Buy	25,744 +8,079	+46%	+$411K	0.01%	741
2020 Q2	$710K	Buy	+17,665	New	+$656K	﹤0.01%	1063
2017 Q3	–	Sell	-136	Closed	-$10K	–	2369
2017 Q2	$10K	Buy	+136	New	+$8.03K	﹤0.01%	2389

Other funds holding FBIO

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Panagora Asset Management's FBIO Position: Q2 2026 in Review

Panagora Asset Management increased its Fortress Biotech (FBIO) stake by 17% in Q2 2026, buying an estimated $24.1K and bringing the position to 66,025 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

Panagora Asset Management first reported a position in FBIO in Q2 2017 and has held it in 11 quarters since. The position peaked at $1.56M in Q3 2020. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

Panagora Asset Management held 66,025 shares of Fortress Biotech worth $202K as of Q2 2026.
Panagora Asset Management bought 9,357 Fortress Biotech shares in Q2 2026, an estimated $24.1K.
Fortress Biotech made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #1125 holding.
Panagora Asset Management first reported a position in Fortress Biotech in Q2 2017 and has held it in 11 quarters since.
Panagora Asset Management's Fortress Biotech position peaked at $1.56M in Q3 2020.
55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.